Dialysis equipment market size was worth USD 18.1 billion in 2019 and is expected to reach USD 24.9 billion by 2024, with a CAGR of 6.56 percent during 2019 to 2024, predicts Market Data Forecast. Some of the factors like increasing aging population, rising incidence of kidney diseases, increasing number of diabetes and hypertension patients, and technological advancements in the healthcare industry are driving the market. According to the World Health Organization, a large population base in developing and developed countries suffers from diabetic and pre-diabetic condition. Moreover, with an increase in income levels, there is an increase in the standard of living as well as rise in calorie-rich food intake that further escalates risk of diabetes among the population. High blood glucose levels in diabetic patients thus increase the risk of kidney-related diseases, such as diabetic nephropathy that requires dialysis treatment. Growing prevalence of diabetes-associated kidney diseases should prove beneficial for the overall business expansion. However, factors like low awareness about kidney disease treatment and decreasing medical reimbursements for dialysis treatment are restricting the growth of the market.
Key players of this industry include Davita Healthcare Partners; Fresenius Medical Care AG & Co. Ka; Baxter International; Diaverum Deutschland GmbH; B. Braun Melsungen; Nipro Corporation; Nikkiso; Nxstage Medical; Mar Cor Purification; Terumo Corporation; Asahi Kasei Medical; Rockwell Medical; Hemoclean; and Teleflex Incorporated.